Search
Products
Community
Markets
News
Brokers
More
IN
Get started
Markets
/
United Kingdom
/
ETF market
/
ARKG
/
Analysis
ARK INVEST UCITS ICAV GENOMIC REVOLUTION UCITS ETF USD ACC
ARKG
London Stock Exchange
ARKG
London Stock Exchange
ARKG
London Stock Exchange
ARKG
London Stock Exchange
Market closed
Market closed
No trades
See on Supercharts
Overview
Analysis
Discussions
Technicals
Seasonals
Key stats
Assets under management (AUM)
8.16 M
USD
Fund flows (1Y)
5.95 M
USD
Dividend yield (indicated)
—
Discount/Premium to NAV
−2.7%
Shares outstanding
1.53 M
Expense ratio
0.79%
About ARK INVEST UCITS ICAV GENOMIC REVOLUTION UCITS ETF USD ACC
Issuer
ARK Investment Management LP
Brand
ARK
Home page
europe.ark-funds.com
Inception date
Apr 12, 2024
Index tracked
No Underlying Index
Replication method
Synthetic
Management style
Active
Primary advisor
ARK Investment Management LLC
ISIN
IE000O5M6XO1
The investment objective of the Fund is to generate long term capital growth (5 years or more)
Show more
Classification
Asset Class
Equity
Category
Sector
Focus
Theme
Niche
Genomic advancements
Strategy
Active
Geography
Global
Weighting scheme
Proprietary
Selection criteria
Proprietary
Returns
1 month
3 months
Year to date
1 year
3 years
5 years
Price performance
—
—
—
—
—
—
NAV total return
—
—
—
—
—
—
What's in the fund
As of February 20, 2025
Exposure type
Stocks
Bonds, Cash & Other
Health Technology
Technology Services
Stocks
99.61%
Health Technology
76.28%
Technology Services
15.73%
Health Services
7.60%
Bonds, Cash & Other
0.39%
Cash
0.39%
Stock breakdown by region
91%
8%
North America
91.69%
Europe
8.31%
Latin America
0.00%
Asia
0.00%
Africa
0.00%
Middle East
0.00%
Oceania
0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows